PExA Overview

  • Founded

  • 2002

Founded
  • Status

  • Public

  • Employees

  • 3

Employees
  • Stock Symbol

  • PEXA B

Stock Symbol
  • Share Price

  • $0.05

  • (As of Tuesday Closing)

PExA General Information

Description

PExA AB develops, manufactures and markets a research tool to study respiratory diseases including asthma and chronic obstructive pulmonary disease, COPD. Its product includes PExA 2.0.

Contact Information

Website
www.pexa.se
Ownership Status
Publicly Held
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Stock Exchange
SAT
Primary Office
  • Erik Dahlbergsgatan 11 A
  • Floor 2, South East
  • 411 26 Gothenburg
  • Sweden
+46 070-586 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PExA Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.05 $0.05 $0.04 - $0.09 $2.29M 42.3M 85.7K

PExA Financials Summary

In Thousands,
USD 		TTM 31-Mar-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 1,047 770 3,035 3,467
Revenue 569 594 252 73
EBITDA (356) (379) (770) (725)
Net Income (403) (424) (903) (858)
Total Assets 2,117 2,386 2,907 1,733
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PExA Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PExA‘s full profile, request access.

Request a free trial

PExA Patents

  • 7

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

PExA Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3068942-A1 New system for collecting exhaled particles Pending 10-Jul-2017 000000000
EP-3651642-B1 New system for collecting exhaled particles Active 10-Jul-2017 000000000
EP-3651642-A1 New system for collecting exhaled particles Active 10-Jul-2017 000000000
JP-2020534511-A New system for collecting exhaled particles Active 10-Jul-2017 000000000 0
JP-7067811-B2 A new system for collecting exhaled particles Active 10-Jul-2017 A61B5/097 0
To view PExA’s complete patent history, request access »

PExA Executive Team (3)

Name Title Board Seat Contact Info
Erik Ekbo Chief Executive Officer
Anna-Carin Olin Founder & Board Member
Svante Höjer Ph.D Manager, Engineering and Design
To view PExA’s complete executive team members history, request access »

PExA Board Members (5)

Name Representing Role Since
Anna-Carin Olin PExA Founder & Board Member 000 0000
Bertil G. Larsson PExA Board Member 000 0000
Claes Holmberg Ph.D Self Chairman of the Board 000 0000
Klementina Österberg PExA Board Member 000 0000
Lena Kajland Wilén PExA Board Member 000 0000
To view PExA’s complete board members history, request access »

PExA Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PExA Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PExA‘s full profile, request access.

Request a free trial